EyePoint Pharmaceuticals
EYPT
#5179
Rank
ยฃ1.13 B
Marketcap
ยฃ13.72
Share price
2.99%
Change (1 day)
97.65%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ38.68 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ38.68 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ65.31 M-6.36%
2023-12-31ยฃ69.74 M0.47%
2022-12-31ยฃ69.42 M18.63%
2021-12-31ยฃ58.51 M9.01%
2020-12-31ยฃ53.68 M8.9%
2019-12-31ยฃ49.29 M
2018-06-30ยฃ45.41 M1005.92%
2017-06-30ยฃ4.1 M-49.03%
2016-06-30ยฃ8.05 M40.44%
2015-06-30ยฃ5.73 M26.7%
2014-06-30ยฃ4.52 M-19.47%
2013-06-30ยฃ5.62 M26.72%
2012-06-30ยฃ4.43 M-26.44%
2011-06-30ยฃ6.03 M-8.27%
2010-06-30ยฃ6.57 M-20.11%
2009-06-30ยฃ8.23 M-36.27%
2008-06-30ยฃ12.91 M36.4%
2007-06-30ยฃ9.46 M-61.43%
2006-06-30ยฃ24.55 M369.9%
2005-06-30ยฃ5.22 M606.17%
2004-06-30ยฃ0.73 M107.31%
2003-06-30ยฃ0.35 M
2001-06-30ยฃ0.1 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
ยฃ91.17 M 135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
ยฃ2.36 M-93.89% Bahamas